Skip to main content

Antiplatelet and Antithrombotic Therapy in PCI

  • Chapter
  • First Online:
Practical Manual of Interventional Cardiology

Abstract

Advances in drug stent-eluting technology, antiplatelet pharmacotherapy, and novel parenteral and oral anticoagulants have led to a constant evolution in periprocedural antithrombotic strategy. The following chapter outlines our cardiac catheterization laboratory’s current approach to antiplatelet and anticoagulation therapy in various clinical settings based on current guidelines, data, and expert opinion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gallagher AM, van Staa TP, Murray-Thomas T, et al. Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes. BMJ Open. 2014;4:e003839.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003;290:268.

    Article  Google Scholar 

  3. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864.

    Article  CAS  PubMed  Google Scholar 

  4. Lip GY. Implications of the CHA2DS2-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. Am J Med. 2011;124:111.

    Article  PubMed  Google Scholar 

  5. Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107.

    Article  CAS  PubMed  Google Scholar 

  6. National Collaborating Centre for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. London: Royal College of Physicians; 2006.

    Google Scholar 

  7. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369.

    Article  PubMed  Google Scholar 

  8. O’shea JC, Madan M, Cantor WJ, et al. Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention. Am Heart J. 2000;149(2):S36–43.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annapoorna Kini MD, MRCP, FACC .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Patel, R., Rajamanickam, A., Kini, A. (2014). Antiplatelet and Antithrombotic Therapy in PCI. In: Kini, A., Sharma, S., Narula, J. (eds) Practical Manual of Interventional Cardiology. Springer, London. https://doi.org/10.1007/978-1-4471-6581-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6581-1_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6580-4

  • Online ISBN: 978-1-4471-6581-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics